TU/e spin-off STENTit awarded for two prizes during the Global Entrepreneurship Summit

June 7, 2019

Prince Constantijn and Miss Ivanka Trump award STENTiT for both Outstanding Women Entrepreneur and GIST Health Runner-Up during the GES.

As winner of the Academic Start-Up Competition, STENTiT was given the opportunity to present its technology to a global audience at the Global Entrepreneurship Summit (GES) in The Hague on June 4.

The TU/e spin-off participated in the Global Innovation through Science & Technology (GIST) Catalyst pitch competition, organised in collaboration with the Dutch Academic Start-Up Competition. STENTiT has won both the Outstanding Women Entrepreneur in Science and Technology award, as well as the Runner-Up prize in the Health focus area.


STENTiT founders Bart Sanders and Sol Cabrera developed a technology to restore diseased arteries using regenerative stents. These unique bioresorbable devices allow for minimally invasive implantation to provide instant support to the lesion while triggering a natural healing response using the patient’s own circulating blood cells to reconstruct a whole new artery. Vascular regeneration will improve long-term clinical outcomes for millions of patients while reducing health-care costs.

About GIST

The GIST Catalyst competition began with over 4,000 applications from all over the world, which narrowed down to a list of top 30 companies giving the opportunity to pitch their business at the GES 2019, divided over the 5 focus sectors including Health.


In addition to exposure on this global event, STENTiT has won $38.000 in credits from private sector sponsors IBM, Google and AWS, where in addition a booth at CES will be provided and a 1-on-1 mentorship session with the Silicon Valley Bank.

Watch the video of the award ceremony by clicking on the Youtube icon below.